Member Info for mulledwine

There is a strong sense that the London Stock Exchange is not sure where to go next after the unexpected failure of its merger with TMX, of Canada. I do not believe that the LSE will be bid for by anyone. This leaves its shares at the top end of their trading range, up 33½p at £10.30½p yesterday and on about 13 times’ this year’s earnings. Unless you believe that a bid is in prospect, taking a bit of profit looks sensible, says the Times’s Martin Waller. The Independent asks: is there any point in discussing the London Stock Exchange's financials when considering the shares? Even if yesterday's trading statement were dreadful (it wasn't) it would hardly matter – surely the only relevant issue is whether the LSE will be bid for and when? The group trades on a forward earnings multiple of 12 times, which is hardly demanding, and adds to the case for in buying once again. Buy, the newspaper says.

Pursuit Dynamics made its name in with some whizzy technology, including its reactor system used in brewing and its atomising system for putting out fires which involves injecting high-speed gas into fluid. Merchant Securities, whose analysts reckon that Pursuit will start to generate in the next financial year, put the stock on around 15 times forward earnings for next year. This is encouraging, not least because the share price has tumbled since peaking at 700p in December, says the Independent, which recommends buying the shares.

International Personal Finance is the emerging markets doorstep lending business spun off Provident Financial in 2007. Its own markets, mainly in Eastern Europe, are resilient and not yet affected by events in the southern half of the eurozone. Although existing markets can provide growth over the next five years, thereafter it needs to move elsewhere. Expect more guidance with the finals next March; for now, the shares are on ten times this year’s earnings and are a straight bet on whether you expect further euro-contagion. Personally, I do, says Waller in the Times.

Playtech’s spot of nastiness with William Hill over their joint online venture is over and it is out there strongly marketing its gaming software. A deal with Gala Coral was was confirmed yesterday and the company is in talks with other potential customers. The shares have always attracted a lower multiple than rivals and, after yesterday’s 9% rise to 369¼p, sell on about ten times’ this year’s earnings, which looks about right ahead of any further developments, the Times says.

Outlook Economic pressures continue and consumer expenditure in our market has weakened in the last couple of months with the short term outlook remaining uncertain. Despite these near term challenges, our long term focus remains on strengthening the business, lowering costs, driving sustainable revenue and improving customer experience as we better utilise our well placed sites and brands.

http://www.investegate.co.uk/Article.aspx?id=201107210700137756K

Interim Management Statement Renold, a leading international supplier of industrial chains and related power transmission products, is today issuing its interim management statement covering the period from 1 April 2011 to the current date. On 31 May 2011 Renold announced its results for the year ended 31 March 2011. The encouraging trend in sales and growth in order intake noted at that time has continued throughout the first quarter of the current financial year. Order intake has surpassed sales in all three months of the quarter and underlying* sales were 12% higher than in the comparable period last year. Both operating divisions have experienced robust levels of growth with Torque Transmission sales 16% ahead of the comparable period in the prior year and Chain sales 10% ahead. Viewed on a geographical basis, our operations in Australasia, China, and India each saw revenue growth in excess of 20%. This level of growth is consistent with achieving the market forecast of doubling our adjusted operating profit in the current financial year. There have been no other significant changes in the position of the Company over the period since the publication of the full year results for the year ended 31 March 2011.

http://www.investegate.co.uk/Article.aspx?id=201107210700117738K

Chief Executive, Matthew Ingle, said: "We are pleased to have increased sales and profit in what are demanding market conditions. This performance is testament to the strengths of our business model and the efforts of all our staff. It also gives us confidence to continue to invest in the long term growth of the business. "We expect market conditions to continue to be challenging for the rest of the year but remain confident about our performance, which is in line with our expectations for 2011."

Business developments · Investment in the future growth of the business continues: - new products introduced across whole spectrum of offer; - five new depots opened so far in 2011, bringing total to 494; - capital expenditure totalled £7.9m; - orders placed for new cabinet production lines at Runcorn and Howden. · Further mitigation of legacy property liability, with termination of leases on four more legacy properties since the Interim Management Statement, bringing the total so far this year to 12. Current trading · Howden Joinery UK depot total revenue increased by 10.5% in the first period of the second half of the year (period 7) compared with the same period last year - this included the benefit of a price rise being initiated and some associated pull-through effect on sales. · Management's expectations for the year remain unchanged.

Financial results · Howden Joinery UK depot revenue increased by 4.9% to £334.9m, up 2.4% on a same depot basis. Sales in the last three periods (since mid-March), during which prices were unchanged from 2010, were up 3.7%. Group revenue was £341.7m (2010: £324.7m); · Gross profit margin rose from 58.1% to 59.3%; · Operating profit increased to £25.5m (2010: £24.5m); · Profit before tax rose by £1.9m to £23.5m (2010: £21.6m); · Basic earnings per share increased to 2.8p (2010: 2.3p); · Net cash of £5.1m at 11 June 2011 (25 December 2010: £35.0m net cash, 12 June 2010: £2.7m net debt), after payments totalling £17.2m relating to legacy properties and a payment, in excess of the operating charge, of £17.9m to the Group's pension schemes (the 'pension deficit contribution').

http://www.investegate.co.uk/Article.aspx?id=201107210700127750K

Commenting on the performance, Ed Ware, CEO of 32Red, said: "This exceptional year on year growth is particularly pleasing given the strong trading experienced during the comparative period. Our marketing has become more effective and has yielded encouraging results. We will build investment in this area throughout the remainder of the year. "32Red was delighted to have renewed the sponsorship of Swansea City Football Club for a further three years in February, and we congratulate the Club on promotion to the Premier league. "While the focus remains in the UK, the Board continues to monitor developments in Europe."

Casino Performance Overall performance reflects the continued excellent trading at the Company's flagship operation, the 32Red Casino:- · Gross Win (revenue) £9.5m, up 41% on 2010 · Active casino customers 21,745 up 12% on H1 10 · Casino player yield £438, up 22% on H1 10 · New Casino players 13,901, up 13% on H1 10 · Casino cost per acquisition: £118 (H1 10: £86; FY 2010: £119) Current Trading and Outlook for the Full Year Gross Win for the first nineteen days in July are up 67% on the corresponding period in 2010. The strong H1 trading performance and current trading is likely to see the Company deliver revenues and profits that are significantly ahead of current market expectations for 2011. Trade Mark infringement case In October 2010, 32Red was successful in its trade mark action in the High Court against William Hill. As a result of that successful action 32Red is entitled to damages. The level of damages relating to this case and the liability for costs will be assessed at future hearings in the High Court. William Hill have appealed against the decision of the High Court. Dates for all future hearings are awaited.

http://www.halifaxmarketwatch.co.uk/rns.cgi?username=&ac=&action=news&rns=1&view=full&story_id=4376564

Matthijs Guichelaar from Zestiq said "Zestiq sees a huge market potential for BlueGen in the Netherlands. With its dense gas network, large gas reserves in the North and growing interest in distributed generation, we think the Netherlands and the BlueGen are a perfect match. We see great possibilities in carbon reduction and smartgrid applications. Together with Eneco we are looking forward to starting to make sales." Brendan Dow, Managing Director of Ceramic Fuel Cells said "We are very pleased to have appointed Zestiq as another sales channel for BlueGen, this time in the important Dutch market. Zestiq and their utility partners will drive BlueGen sales in this market to build on our sales channels in the UK and other key markets."

Ceramic Fuel Cells appoints BlueGen distributor in The Netherlands 21 July 2011 Ceramic Fuel Cells Limited (AIM/ASX: CFU), a leading developer of high efficiency and low emission power products for homes and other buildings, has signed a distribution agreement with Zestiq B.V., for Zestiq to market and sell Ceramic Fuel Cells' BlueGen gas-to-electricity products in The Netherlands. Zestiq is part of the consortium of innovative companies which in March 2011 bought and installed a BlueGen in a 17th century canal house "De Groene Bocht" in the centre of Amsterdam. The aim of Zestiq is to accelerate 'clean technology' which is market ready. By developing smart business models for the different technologies, Zestiq aims to significantly reduce the time to mass market. Zestiq and its partners will market and sell BlueGen units to small commercial and residential customers in The Netherlands. The units will be installed and maintained by the service company of Eneco, Eneco Installatie Bedrijven. The other members of the consortium include several leading energy companies in The Netherlands: Liander is a distribution company with 2.9 million electricity customers and 2.1 million gas customers. GasTerra is an international natural gas trading company owned by Royal Dutch Shell, Exxon Mobil and the Dutch Government. Responsibility for the planet and for society go hand in hand at GasTerra, which is why sustainability is an important component of GasTerra's policy. The company supports the development of gas technologies, such as BlueGen units, that could make a significant contribution to the transition to sustainable sources of energy. A BlueGen unit is also installed at the home of a Director of GasTerra. The other consortium member, Eneco, currently provides services for a range of heating and cooling technologies, including other small scale combined heating and power products. Eneco invests in sustainable energy sources such as wind, hydro and solar energy, biomass, heating and cooling and decentralised, local generation of energy. Eneco is active in the North West European market with operations in Belgium, France, Germany and the United Kingdom. Eneco is mission partner of the World Wildlife Fund (WWF) and the world's first energy company to participate in the international Climate Saver programme.

http://www.investegate.co.uk/Article.aspx?id=201107210700177928K

"We are very pleased to reach such an important milestone with the EU approval," said Nazmul Hassan, Managing Director of Beximco Pharma. "This approval is a testimony to the high standards of quality and compliance practices put in place by the Company. This is an important step towards our aspiration to become a global generic drug player, and particularly for building our presence in the regulated markets of US and EU."

EU GMP Certificate Received Beximco Pharmaceuticals Limited ("BPL" or "the Company"; AIM Symbol: BXP), the fast-growing manufacturer of generic pharmaceutical formulation products, active pharmaceutical ingredients and intravenous fluids, today announces that it has received GMP ("Good Manufacturing Practices") accreditation from the Regulatory Authority of Austria for its oral solid (tablets and capsules) and sterile eye drop facilities at Tongi, Dhaka. The approval received from the Austrian Drug Authority will be recognized throughout the European Union (EU) by Mutual Recognition between the member countries. This is a significant milestone for the company which should facilitate exports to the lucrative generic drug markets of Europe.